Home
>
US Stocks
>
Pieris Pharmaceuticals Inc
Pieris Pharmaceuticals Inc
PIRS

Pieris Pharmaceuticals Inc (PIRS)

$4.323.14%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
4.29
Today Low/High
4.23 / 4.32
52 Week Low/High
$1.7 / $5.09
Market Cap
$255.5M

Company Details

Pieris Pharmaceuticals Inc.is a clinical-stage biotechnology company that discovers and develops Anticalin protein-based drugs to target validated disease pathways in a unique and transformative way. Its pipeline includes inhalable Anticalin proteins to treat respiratory diseases and immuno-oncology multi-specifics tailored for the tumor microenvironment. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the clinic and by partnerships with leading pharmaceutical companies. Anticalin® is a registered trademark of Pieris.
Organisation
Pieris Pharmaceuticals Inc
Headquaters
Boston, Massachusetts, US
Employees
117
Industry
Health Technology
CEO
Stephen Yoder

Discover more

Frequently Asked Questions

What is Pieris Pharmaceuticals Inc (PIRS) share price today?

Can Indians buy Pieris Pharmaceuticals Inc (PIRS) shares?

How can I buy Pieris Pharmaceuticals Inc (PIRS) shares from India?

Can Fractional shares of Pieris Pharmaceuticals Inc (PIRS) be purchased?

What are the documents required to start investing in Pieris Pharmaceuticals Inc (PIRS) stocks?

We are a SEBI registered investement advisor